🇺🇸 FDA
Patent

US 6509492

Tannate compositions and methods of treatment

expired A61KA61K31/137A61K31/4402

Quick answer

US patent 6509492 (Tannate compositions and methods of treatment) held by First Horizon Pharmaceutical Corporation expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
First Horizon Pharmaceutical Corporation
Grant date
Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/137, A61K31/4402, A61K31/485